ANNX CIK: 1528115

Annexon, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
248
FY23:
264
FY24:
316
FY25:
242
(positive)
Change from FY21 to FY25
millions USD
FY21:
39.3
FY22:
37.0
FY23:
33.8
FY24:
33.6
FY25:
35.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
287
FY22:
285
FY23:
298
FY24:
350
FY25:
278

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
21.7
FY22:
22.4
FY23:
17.9
FY24:
30.5
FY25:
42.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
33.4
FY22:
31.5
FY23:
29.2
FY24:
26.5
FY25:
23.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
231
FY23:
251
FY24:
293
FY25:
212
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
287
FY22:
285
FY23:
298
FY24:
350
FY25:
278

All amounts in millions USD Data sources:SEC EDGARTwelve Data